Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Isofol Medical AB ( (SE:ISOFOL) ) is now available.
Isofol’s nomination committee has proposed the re-election of all current board members and the appointment of major shareholder Christian Haglund as a new director at the company’s annual general meeting on May 19, 2026. The proposal would expand the board to six members, reflecting a stronger investor presence through Haglund, a seasoned finance and capital markets executive who holds about 10.5% of Isofol’s shares and sits on several other Swedish corporate boards.
Haglund, co-founder of real estate groups Intea Fastigheter and Vacse and former CFO and deputy CEO at Intea, brings extensive experience in financial investments, including previous roles at Atlas Copco and as an advisor to the Epiroc Group’s Swedish pension fund. The nomination committee, which includes Haglund himself among other large shareholders, plans to publish full proposals ahead of the meeting, signaling a governance approach that closely aligns board composition with the company’s key owners and capital markets expertise.
The most recent analyst rating on (SE:ISOFOL) stock is a Hold with a SEK0.64 price target. To see the full list of analyst forecasts on Isofol Medical AB stock, see the SE:ISOFOL Stock Forecast page.
More about Isofol Medical AB
Isofol Medical AB is a Sweden-based biopharmaceutical company focused on improving outcomes and quality of life for patients with severe cancers. Its lead drug candidate, arfolitixorin, is being developed to enhance first-line standard treatment for solid tumors and is currently in a phase Ib/II study in colorectal cancer, one of the world’s most common and urgent oncology indications. The company is listed on Nasdaq Stockholm and operates from Gothenburg.
YTD Price Performance: -5.08%
Average Trading Volume: 1,463,084
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK194.7M
For an in-depth examination of ISOFOL stock, go to TipRanks’ Overview page.